971 filings
Page 11 of 49
SC 13G/A
SRNEQ
Sorrento Therapeutics, Inc.
1 Feb 21
Sorrento Therapeutics / China In Shine Investment ownership change
4:32pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
27 Jan 21
Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients
12:00am
4
SRNEQ
Sorrento Therapeutics, Inc.
26 Jan 21
Sorrento Therapeutics / Dorman Followwill ownership change
5:24pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
11 Jan 21
Other Events
6:04am
8-K
SRNEQ
Sorrento Therapeutics, Inc.
23 Dec 20
Other Events
6:01am
8-K
SRNEQ
Sorrento Therapeutics, Inc.
15 Dec 20
Entry into a Material Definitive Agreement
5:25pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
9 Dec 20
Other Events
9:00am
8-K
SRNEQ
Sorrento Therapeutics, Inc.
8 Dec 20
Sorrento Receives Licensure from the State of California for Clinical Testing Laboratory (CLIA) Allowing for Clinical Sample Testing
9:36pm
424B5
SRNEQ
Sorrento Therapeutics, Inc.
4 Dec 20
Prospectus supplement for primary offering
5:15pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
4 Dec 20
Entry into a Material Definitive Agreement
5:10pm
424B3
SRNEQ
Sorrento Therapeutics, Inc.
4 Dec 20
Prospectus supplement
5:05pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
27 Nov 20
Other Events
8:00am
8-K
SRNEQ
Sorrento Therapeutics, Inc.
17 Nov 20
Other Events
6:01am
4
SRNEQ
Sorrento Therapeutics, Inc.
13 Nov 20
Sorrento Therapeutics / Najjam Asghar ownership change
5:12pm
10-Q
2020 Q3
SRNEQ
Sorrento Therapeutics, Inc.
Quarterly report
9 Nov 20
12:00am
8-K
SRNEQ
Sorrento Therapeutics, Inc.
29 Oct 20
Other Events
9:00am
8-K
SRNEQ
Sorrento Therapeutics, Inc.
27 Oct 20
Termination of a Material Definitive Agreement
4:09pm
S-8
SRNEQ
Sorrento Therapeutics, Inc.
22 Oct 20
Registration of securities for employees
5:25pm
S-8
SRNEQ
Sorrento Therapeutics, Inc.
22 Oct 20
Registration of securities for employees
5:25pm
424B3
SRNEQ
Sorrento Therapeutics, Inc.
21 Oct 20
Prospectus supplement
4:16pm